Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

8

Number of overlapping holdings

26.7%

% of FBT's 31 holdings also in CANC

17.0%

% of CANC's 47 holdings also in FBT

Overlap by Weight
Sector Drift (FBT minus CANC)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in FBT
Weight
in CANC
Overlap
GENMAB A/S SPONSORED ADR 3.8% 4.0% 3.8%
EXELIXIS INC 3.7% 4.0% 3.7%
AMGEN INC 3.2% 3.4% 3.2%
BEIGENE LTD. SPONSORED ADR 3.6% 2.8% 2.8%
ARGENX SE ADR 3.1% 1.5% 1.5%

Position Highlights (Non-Overlapping Exposures)
FBT Overweight Relative to CANC
ACADIA PHARMACEUTICALS INC 4.6%
NEUROCRINE BIOSCIENCES INC 4.2%
ALNYLAM PHARMACEUTICALS INC 4.0%
EXACT SCIENCES CORP 3.7%
INCYTE CORP 3.7%
BIOGEN IDEC INC 3.5%
NATERA INC 3.5%
METTLER-TOLEDO INTERNATIONAL 3.4%
ALKERMES PLC 3.4%
BIONTECH SE SPONSORED ADR 3.4%
FBT Underweight Relative to CANC
ELI LILLY & CO -5.3%
ROCHE HOLDINGS LTD-SPONS ADR -5.2%
REVOLUTION MEDICINES, INC. -5.2%
NOVARTIS AG -4.3%
ASTRAZENECA PLC -4.2%
BRIDGEBIO PHARMA, INC. -4.2%
MERUS N.V. -3.8%
BRISTOL-MYERS SQUIBB CO -3.6%
NUVALENT, INC. CLASS A -3.4%
ZAI LAB LTD. UNSPONSORED ADR -3.3%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY